These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 119888)

  • 21. Lipid substitution of mitochondrial monoamine oxidase can lead to the abolition of clorgyline selective inhibition without alteration in the A/B ratio assessed by substrate utilisation.
    Houslay MD
    Biochem Pharmacol; 1980 Dec; 29(23):3211-3. PubMed ID: 7447959
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of mitochondrial monoamine oxidase of the rat uterus and liver by clorglyine, pargyline and harmine.
    Grosso DS; Gawienowski AM
    Biochem Pharmacol; 1976 Apr; 25(8):957-61. PubMed ID: 178322
    [No Abstract]   [Full Text] [Related]  

  • 23. Modification of substrate-inhibitor affinities of human platelet monoamine oxidase B in vitro.
    Szutowicz A; Tomaszewicz M; Orsulak PJ
    J Biol Chem; 1989 Oct; 264(30):17660-4. PubMed ID: 2509446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of clorgyline and (-)deprenyl on the deamination of normetanephrine and noradrenaline in strips and homogenates of the canine saphenous vein.
    Caramona MM; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):396-400. PubMed ID: 3921855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Transformation of mitochondrial monoaminoxidases types A and B].
    Shatemirova KK; Vervkina IV; Gorkin VZ
    Biull Eksp Biol Med; 1977 Jun; 83(6):669-70. PubMed ID: 884293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible mechanisms underlying the differential effects of selective inhibitors of type A and type B monoamine oxidase on intraocular pressure in the cat.
    Colasanti BK
    J Ocul Pharmacol; 1986; 2(1):1-8. PubMed ID: 3139805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of clorgyline and deprenil on corticosterone levels in rats.
    Ventura MA
    Eur J Pharmacol; 1982 Jul; 81(3):349-55. PubMed ID: 6214412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Observations on the inhibition of rat liver monoamine oxidase by clorgyline.
    Lyles GA; Greenawalt JW
    Biochem Pharmacol; 1977 Dec; 26(23):2269-74. PubMed ID: 588309
    [No Abstract]   [Full Text] [Related]  

  • 29. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
    Azam M; Jain S; Baquer NZ
    Biochem Pharmacol; 1990 Nov; 40(10):2215-8. PubMed ID: 2123104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective inhibition of MAO-A but not MAO-B activity increases rat pineal melatonin.
    Oxenkrug GF; McCauley R; McIntyre IM; Filipowicz C
    J Neural Transm; 1985; 61(3-4):265-70. PubMed ID: 2580945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.
    Glover V; Pycock CJ; Sandler M
    Br J Pharmacol; 1983 Sep; 80(1):141-8. PubMed ID: 6418254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation.
    Braestrup C; Andersen H; Randrup A
    Eur J Pharmacol; 1975 Nov; 34(1):181-7. PubMed ID: 1241962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-hydroxytryptamine: a substrate for rat liver mitochondrial monoamine oxidase-A and -B.
    Kinemuchi H; Kawaguchi T; Arai Y; Tajima H; Oreland L; Kamijo K
    Jpn J Pharmacol; 1982 Oct; 32(5):954-7. PubMed ID: 6816972
    [No Abstract]   [Full Text] [Related]  

  • 34. Liver monoamine oxidase in the obese-hyperglycaemic (ob/ob) mouse.
    Tong JH; Limson-Zamora M; D'Iorio A; Bégin-Heick N
    Biochem J; 1979 Mar; 177(3):943-9. PubMed ID: 444212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of lipid-depletion on the different forms of monoamine oxidase in rat liver mitochondria.
    Ekstedt B; Oreland L
    Biochem Pharmacol; 1976 Jan; 25(2):119-24. PubMed ID: 1259773
    [No Abstract]   [Full Text] [Related]  

  • 36. Association of monoamine oxidase with lipid--a comparative study mitochondria from Novikoff hepatoma and rat liver.
    Sawyer ST; Greenawalt JW
    Biochem Pharmacol; 1979 Jun; 28(11):1735-44. PubMed ID: 475834
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of beta-fluorophenethylamine analogs on monoamine oxidase substrate preference.
    Meyerson LR; Fuller RW
    Res Commun Chem Pathol Pharmacol; 1978 Sep; 21(3):581-4. PubMed ID: 30122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of type A monoamine oxidase in mouse and rabbit liver mitochondria.
    Suzuki O; Mizutani S; Katsumata Y; Oya M
    Experientia; 1981 Jan; 37(1):18-9. PubMed ID: 6781927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoacylcadaverines as substrates for both monoamine oxidase and diamine oxidase; low rates of activity.
    Suzuki O; Matsumoto T; Oya M; Katsumata Y; Stepita-Klauco M
    Experientia; 1980 May; 36(5):535-7. PubMed ID: 6769699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.